Moteur de recherche d’entreprises européennes
UK funding (1 055 868 £) : Modélisation atomistique de nouvelle génération pour la chimie et la biologie médicinales Ukri01/10/2020 UK Research and Innovation, Royaume Uni
Vue d’ensemble
Texte
Modélisation atomistique de nouvelle génération pour la chimie et la biologie médicinales
| Abstract | Nobel Laureate Richard Feynman in his Lectures on Physics famously remarked that "...everything that living things do can be understood in terms of the jigglings and wigglings of atoms". This deceptively simple statement highlights the difficulty that structural biologists, medicinal chemists and computational scientists are faced with when attempting to understand human health and disease. We are used to thinking about a static, isolated picture of objects at the atomic scale, but often it is the dynamics (the "jigglings and wigglings") of the system and its environmental interactions that determine the underlying science, such as the role of intrinsically disordered proteins in neurodegenerative diseases or the possible link between quantum entanglement and molecular vibrations in biological photosynthesis. Twentieth century science not only set the challenge of studying life at the level of the structure and dynamics of atoms, but also provided (in theory) the solution, through the laws of quantum mechanics and the famous Schroedinger equation. Quantum mechanics explains the fundamental behaviour of matter at the atomic scale, and smaller. It enables scientists to make predictions about materials that are inaccessible to experiment, such as the structure of solid hydrogen in a star's core. At a more everyday level, quantum mechanics is routinely used by researchers in the microelectronics and renewable energy industries to rapidly scan multitudes of hypothetical materials compositions. In this way, the costly manufacturing process of the new materials need only begin once the desired properties have been predicted. However, quantum mechanics does not directly enable scientists to understand the biomolecular origins of disease, or to design new medicines to combat it. The reason for this comes down to Feynman's statement. It is infeasible to solve (even approximate) equations of quantum mechanics for the length and time scales sufficient to model all of the atomistic movements that need to take place, for example, for a drug molecule to find its target. Instead, computational chemists use a much simplified computational model, known as a force field, to estimate the dynamics of atoms. The force field models the atoms as bonded together in a molecule by springs, and interacting with other atoms through electrostatic and van der Waals forces, which are much stronger than gravity at the atomic scale. The strengths of these interactions are modelled by thousands of adjustable parameters, which have been manually tuned to reproduce experimental data over a period of many decades. We are reaching a stagnation point where accuracy is urgently needed for computer-aided design of new medicines, but parameter tuning delivers only small improvements. My vision for this UKRI Future Leaders Fellowship is to build a multi-disciplinary team that will work together to close the accuracy gap between quantum mechanics, and the approximate force fields used in biology and medicine. By working with international coding efforts, I will build the theory and software infrastructure required to dispense with these adjustable force field parameters, and instead derive them directly for the system under study, such as a protein implicated in disease. This will enable me to build more accurate computational models of the electrostatic and van der Waals interactions that determine the strength of binding of potential drugs to their targets. By crossing disciplinary boundaries to train in data science and machine learning, I will deploy the expertise that has been made famous for its applications in face and speech recognition, to create a spectrum of tools for speeding up the assignment of parameters and improving the accuracy of force field design. Finally, by undertaking secondments in the pharmaceutical industry, I will ensure that the developed methods will be used for the cost efficient design of the next generation of medicines. |
| Category | Fellowship |
| Reference | MR/T019654/1 |
| Status | Active |
| Funded period start | 01/10/2020 |
| Funded period end | 30/09/2024 |
| Funded value | £1 055 868,00 |
| Source | https://gtr.ukri.org/projects?ref=MR%2FT019654%2F1 |
Participating Organisations
| Newcastle University |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : University OF Newcastle Upon Tyne CHARITY, Newcastle upon Tyne, Royaume Uni.
Les visualisations de "Newcastle University - UK funding (1 055 868 £) : Modélisation atomistique de nouvelle génération pour la chimie et la biologie médicinales"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
